The Past: "This CEO is amazing!" Current: "This CEO lied

New Post Public Reply Private Reply Replies (0) Message Board
joey68
651
The Past: "This CEO is amazing!"

Current: "This CEO lied to us!"

Future: "This CEO is amazing!"

..repeat endlessly

Don't go long. Just make a friggen' profit, and reinvest in a lower price stock. geesh.

Iconic Brands, Inc. (ICNB) Stock Research Links

ICNB Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bloomberg Law Awards Series Celebrates Legal Excellence

Updated Category News Views 24

New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...

Continue Reading
New Research Awards Target Drug Resistance in Cancers

Updated Category News Views 68

Well, this is a breath of fresh air in the lung cancer scene, let's talk about some promising news for those battling RET-positive cancers. The LUNGevity Foundation and RETpositive have handed out some well-deserved awards to researchers aiming to crack the stubborn nut of drug resistance in RET-positive cancer therapies. Changing the Game for RET-positive Cancer RET gene...

Continue Reading
Personalized Senior Living Guidance Finds Home in South Jersey

Updated Category News Views 7

Shaunique Adams and Her Mission in South Jersey In a world where compassion sometimes feels like it's on short supply, Shaunique Adams is making sure it's at the forefront of her mission. Having experienced the emotional whirlwind of caregiving firsthand, Adams has transformed her personal journey into a mission to serve families navigating similar paths. Through Trua...

Continue Reading
Firmable Climbs G2 Ranks in Sales Intelligence

Updated Category News Views 72

Success stories aren't written overnight, and Firmable's recent leap in G2's rankings proves that point. This AI-native B2B sales powerhouse has muscled its way from #8 to #4 on the global Momentum Grid for Sales Intelligence, marking a dramatic rise that's hard to ignore. Being recognized at this level shows the company's on a solid path, but let's see what makes this...

Continue Reading
Danobatgroup's New HQ in Shanghai Marks Strategic Shift

Updated Category News Views 67

Shanghai Beckons: A Game Changer for Danobatgroup One crisp morning in Shanghai marks a turning point for Danobatgroup. The Spanish heavy-hitter in machine tools has pinpointed the Shanghai Xinzhuang Industry Park in Minhang District for its Asia-Pacific headquarters. It ain't just another blip on the radar—this one's a calculated leap. Location, Location, Location...

Continue Reading
San Diego's Iconic Nightlife Venue Revives as The Quin

Updated Category News Views 140

The ghosts of PLUXX's past are getting a new home at The Quin in San Diego. It's happening in the Gaslamp Quarter, where the familiar pulse of a party will hit the scene once again. Instead of peeling walls and the typical downtown club smell, we've got internationally acclaimed DJ Sam Feldt headlining the Halloween bash—Heaven & Hell. The Quin's Next Chapter Begins on...

Continue Reading
Grupo Elektra's Earnings: Revenue Down, EBITDA Up

Updated Category News Views 49

Grupo Elektra's Third Quarter Snapshot Ever look at a company's quarterly earnings and feel like you're in a game of numbers bingo? Here's Grupo Elektra's latest—revenue down but EBITDA up. That's the headline from Latin America's retail and financial services giant, announcing a healthy Ps.53,297 million in revenue for Q3 2026, slightly dipping compared to last year's...

Continue Reading
Storyteq's AI Edge Earns Gartner Leader Status Again

Updated Category News Views 69

Pioneering AI in Digital Asset Management Alright, folks, this ain't just another tech release to gloss over with your morning coffee—ITG's Storyteq has snagged the 'Leader' title in Gartner's Magic Quadrant for Digital Asset Management. It's no small feat to earn such recognition three years running, and the secret sauce is their advanced AI capabilities. A Unified AI...

Continue Reading
Ascletis' ASC30 Achieves Significant HbA1c Reductions

Updated Category News Views 0

When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...

Continue Reading
Markel Stays the Course: Solid Q3 Results in 2026

Updated Category News Views 70

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Corcept Therapeutics Faces Class Action Amidst FDA Warnings

Updated Category News Views 161

Corcept's Legal Woes: A Major Shareholder Sucker Punch Alright, folks, let’s break down the hot mess that is Corcept Therapeutics. This situation rings eerily familiar—reminds me of those chaotic days during the dot-com bust. Their stock (NASDAQ:CORT), which once basked in the limelight, just took a nosedive—plummeting by 50% after news broke about some serious...

Continue Reading
ZTE and MTN Launch the World's First 5-Band Remote Radio Unit

Updated Category News Views 227

Introduction to Groundbreaking Technology ZTE Corporation, a pioneering provider in integrated technology solutions, has recently partnered with MTN, a key telecommunications operator in Africa, to unveil a significant advancement in mobile network technology. This revolutionary endeavor brings forth the world's first commercial deployment of a 5-band Remote Radio Unit...

Continue Reading
Imperial Brands Sees Share Price Surge After Positive Update

Updated Category News Views 113

Imperial Brands Shares Experience Notable Growth Shares of Imperial Brands (LON: IMB) saw an impressive increase following the company's recent trading update, indicating a strong outlook for the fiscal year. Investors reacted positively, as the tobacco giant confirmed that it is on track to meet its full-year guidance while also revealing plans to boost capital returns...

Continue Reading
Understanding the Disclosures of Warpaint London Plc In Detail

Updated Category News Views 320

Introduction to Warpaint London Plc Public Disclosures When examining the intricacies of financial markets, disclosures play a pivotal role in ensuring transparency and compliance. This article sheds light on the essential public opening position disclosures related to Warpaint London Plc, particularly focusing on key aspects and significant figures that matter. Key...

Continue Reading
Anticipating Dragonfly Energy Holdings' Earnings Release

Updated Category News Views 167

Anticipating Dragonfly Energy Holdings' Earnings Release Dragonfly Energy Hldgs (NASDAQ: DFLI) is gearing up to release its quarterly earnings report soon, with analysts closely monitoring the financial outcomes. Investors have high hopes for this earnings season, eagerly anticipating news that could exceed expectations and provide positive projections for the next...

Continue Reading